Sequana Medical N.V.
SEQUA.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.01 | 0.02 | 0.14 |
| FCF Yield | -16.86% | -6.31% | -27.74% | -11.80% |
| EV / EBITDA | -19.32 | -18.12 | -6.65 | -9.23 |
| Quality | ||||
| ROIC | -291.99% | 260.39% | -289.06% | 1,116.26% |
| Gross Margin | 0.00% | 0.00% | 75.27% | 76.94% |
| Cash Conversion Ratio | 0.54 | 0.23 | 1.12 | 0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | -34.51% | -24.94% | -15.93% | -6.50% |
| Free Cash Flow Growth | -25.06% | 35.86% | 7.10% | 20.46% |
| Safety | ||||
| Net Debt / EBITDA | -7.08 | -4.06 | -1.92 | -1.08 |
| Interest Coverage | -0.70 | -6.92 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.23 | 0.00 | 0.01 | 0.03 |
| Cash Conversion Cycle | 207.55 | 39,691.01 | 1,023.28 | -426.90 |